Etomidate Induces Mitochondrial Dysfunction in Glioma Cancer Cells by Inhibiting Mitochondrial Biogenesis Mediated by CREB/PGC‐1α
Biotechnology and Applied Biochemistry · 2025
DOI: 10.1002/bab.2722 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology and Applied Biochemistry, 2025. Verfasst von Hailiang Shi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The First People's Hospital of Jiangxia District, Wuhan City, Wuhan, Hubei, China. Hauptthemen laut MEDLINE: Etomidate, Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha, Glioma, Cyclic AMP Response Element-Binding Protein. Die Arbeit nennt 52 Literaturangaben. Gefördert von: Hubei Maternal and Child Health Hospital.
Abstract (Originalsprache)
Gliomas are one of the most prevalent types of solid tumors in the brain. Imbalances in mitochondrial metabolism have been implicated in the pathological progression of gliomas. Etomidate, an agonist of the γ‐aminobutyric acid type A (GABAA) receptor, is widely used in clinical settings. In this study, we report a novel pharmacological function of etomidate in regulating mitochondrial metabolism in glioma cancer cells. U87 glioma tumor cells were treated with etomidate (0.5, 1.0, and 2.0 µg/mL) for 24 h. Quantitative real‐time PCR, western blot analysis, mtDNA/nDNA ratio, MitoTracker Red staining, Complex I and IV activity, intracellular ATP levels, and mitochondrial respiration were assessed. First, etomidate exposure inhibited the expression of PGC‐1α in U87 glioma tumor cells. Further investigation revealed that etomidate suppressed the expression of Nrf1 and TFAM, the two key executors of mitochondrial biogenesis. Etomidate treatment led to damage in mitochondrial biogenesis by decreasing the mtDNA/nDNA ratio, reducing the protein expression of cytochrome B, and lowering mitochondrial mass. These changes suggest impaired mitochondrial replication and function. Correspondingly, etomidate exposure induced a “loss of mitochondrial function” by diminishing the activities of Complex I and Complex IV, the mitochondrial respiratory rate (MRR), and ATP generation. These effects highlight the detrimental impact of etomidate on the energy metabolism of glioma cells. Mechanistically, etomidate inactivated the transcription factor CREB by reducing its phosphorylation at Ser133. Activation of CREB with the second messenger cAMP restored the expression of PGC‐1α, the mtDNA/nDNA ratio, Complex IV activity, summarized mitochondrial respiratory rate (MRR), and ATP production. This suggests that CREB activation may serve as a potential therapeutic strategy to counteract etomidate's inhibitory effects on mitochondrial function in glioma cells. Our results suggest that damage to mitochondrial biogenesis is a key step in the anticancer properties of etomidate in gliomas, and the decrease in PGC‐1α and its downstream molecules may be the critical mechanism behind this effect.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The First People's Hospital of Jiangxia District, Wuhan City, Wuhan, Hubei, China.
- Department of Anesthesiology, Ezhou Central Hospital, Ezhou, Hubei, China.
- Department of Anesthesiology, Hubei Maternal and Child Health Hospital, Wuhan, Hubei, China.
ORCID-Profile: Kai Wei
Förderung
- Hubei Maternal and Child Health Hospital
Zitieren
APA
Shi, H., Cao, Z., & Wei, K. (2025). Etomidate Induces Mitochondrial Dysfunction in Glioma Cancer Cells by Inhibiting Mitochondrial Biogenesis Mediated by CREB/PGC‐1α. Biotechnology and Applied Biochemistry. https://doi.org/10.1002/bab.2722
Vancouver
Shi H, Cao Z, Wei K. Etomidate Induces Mitochondrial Dysfunction in Glioma Cancer Cells by Inhibiting Mitochondrial Biogenesis Mediated by CREB/PGC‐1α. Biotechnology and Applied Biochemistry. 2025. doi:10.1002/bab.2722
BibTeX
@article{Shi2025,
author = {Shi, Hailiang and Cao, Zhongcheng and Wei, Kai},
title = {Etomidate Induces Mitochondrial Dysfunction in Glioma Cancer Cells by Inhibiting Mitochondrial Biogenesis Mediated by CREB/PGC‐1α},
journal = {Biotechnology and Applied Biochemistry},
year = {2025},
doi = {10.1002/bab.2722}
}
EUVIMED